Heyman Richard A. (CIK 0001584759)

Latest company ownership

Shares held
216,272
Last filed at
Oct 3, 2025
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q2 2025Q4
Shares held
67,500
Last filed at
Jun 10, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q2 2025Q4
Shares held
20,657
Last filed at
Feb 27, 2023
Confidence Score
50.0
2025Q4
Confidence Score History
2023Q4 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Oct 18, 2024 Oct 22, 2024 Enliven Therapeutics, Inc. Director Sell 48.8 -1,570 -1.03% ✓ $47.1K
Oct 15, 2024 Oct 17, 2024 Enliven Therapeutics, Inc. Director Sell 51.3 -1,270 -0.66% ✓ $35.1K
Oct 4, 2024 Oct 8, 2024 Enliven Therapeutics, Inc. Director Sell 45.0 -2,825 -1.46% ✓ $77.7K
Oct 1, 2024 Oct 3, 2024 Enliven Therapeutics, Inc. Director Sell 52.5 -518 -0.27% ✓ $14.3K
Sep 16, 2024 Sep 18, 2024 Enliven Therapeutics, Inc. Director Sell 51.3 -1,270 -0.65% ✓ $28.5K
Aug 15, 2024 Aug 19, 2024 Enliven Therapeutics, Inc. Director Sell 51.3 -1,270 -0.64% ✓ $29.5K
Jul 31, 2024 Aug 2, 2024 Enliven Therapeutics, Inc. Director Sell 45.0 -2,351 -1.45% ✓ $64.7K
Jul 15, 2024 Jul 17, 2024 Enliven Therapeutics, Inc. Director Sell 51.3 -1,270 -0.63% ✓ $31.5K
Jun 17, 2024 Jun 20, 2024 Enliven Therapeutics, Inc. Director Sell 51.3 -1,270 -0.63% ✓ $27.3K
May 16, 2024 May 20, 2024 Enliven Therapeutics, Inc. Director Sell 51.3 -1,270 -0.63% ✓ $30.1K
Apr 11, 2024 Apr 15, 2024 Enliven Therapeutics, Inc. Director Sell 41.3 -6,964 -2.25% ✓ $167.9K
Mar 19, 2024 Mar 21, 2024 Enliven Therapeutics, Inc. Director Sell 51.3 -1,270 -0.60% ✓ $18.4K
Feb 15, 2024 Feb 20, 2024 Enliven Therapeutics, Inc. Director Sell 51.3 -1,270 -0.60% ✓ $22.1K
Jan 30, 2024 Feb 1, 2024 Enliven Therapeutics, Inc. Director Sell 51.3 -1,270 -0.59% ✓ $20.8K
Dec 21, 2023 Dec 26, 2023 Enliven Therapeutics, Inc. Director Sell 55.0 -216 -0.12% ✓ $2.8K
Dec 19, 2023 Dec 21, 2023 Enliven Therapeutics, Inc. Director Sell 41.3 -4,280 -2.36% ✓ $55.7K
Sep 14, 2021 Sep 16, 2021 Oric Pharmaceuticals, Inc. Director Sell 51.3 -1,388 -0.60% ✓ $34.8K
Sep 10, 2021 Sep 14, 2021 Oric Pharmaceuticals, Inc. Director Sell 52.5 -1,080 -0.47% ✓ $27.1K
Sep 7, 2021 Sep 9, 2021 Oric Pharmaceuticals, Inc. Director Sell 52.5 -1,086 -0.47% ✓ $27.3K
Jun 1, 2021 Jun 2, 2021 PMV Pharmaceuticals, Inc. Director Sell 10.0 -3,900 -79.43% ✓ $126.9K
May 20, 2021 May 24, 2021 Oric Pharmaceuticals, Inc. Director Sell 51.3 -1,400 -0.60% ✓ $35.2K
May 14, 2021 May 18, 2021 Oric Pharmaceuticals, Inc. Director Sell 41.3 -5,874 -2.45% ✓ $148.6K
May 11, 2021 May 13, 2021 Oric Pharmaceuticals, Inc. Director Sell 58.8 -100 -0.04% ✓ $2.5K
Apr 28, 2021 Apr 30, 2021 Oric Pharmaceuticals, Inc. Director Sell 56.3 -200 -0.08% ✓ $5K
Apr 1, 2021 Apr 5, 2021 Oric Pharmaceuticals, Inc. Director Sell 58.8 -100 -0.04% ✓ $2.5K